Global Next Generation Sequencing (NGS) Market - 2025-2033
Global Next Generation Sequencing (NGS) Market Size - Industry Trends & Outlook
The global next-generation sequencing (NGS) market size reached US$ 13.42 Billion in 2024 and is expected to reach US$ 35.92 Billion by 2033, growing at a CAGR of 11.6% during the forecast period 2025-2033.
Sequencing on NGS includes several significant processes. For instance, DNA next-generation sequencing (NGS) calls for library preparation, bioinformatics analysis, DNA fragmentation, enormous parallel sequencing, and variant/mutation identification and interpretation. Furthermore, rising consumer demand for NGS due to the rising availability of products and technologies, an increase in the number of authorized service providers in the market, and an increase in drug discovery research are driving up the next-generation sequencing (NGS) market size.
The market is experiencing a growing demand for products from North American areas due to the rising advancements in this field. Significant competitors like Thermo Fisher Scientific Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., and others are actively operating in the market.
Global Next Generation Sequencing (NGS) Market Dynamics: Drivers & Restraints
The advancements in NGS platforms are expected to drive the market
The increase in demand for next-generation sequencing (NGS) for various applications, novel technology launches, recent developments in therapeutics, surging research, and novel product launches are likely to fuel the global next-generation sequencing (NGS) market size expansion throughout the forecast period.
For instance, in February 2025, Roche launched its proprietary Sequencing by Expansion (SBX) technology, a breakthrough in next-generation sequencing that delivers ultra-fast, high-throughput, and scalable genomic analysis. This innovation enhances the ability to decode complex diseases like cancer and neurodegenerative disorders by providing deeper insights into gene functions and interactions.
Nucleic acid sequencing has benefited from technological advancements in terms of technical proficiency. For instance, in April 2024, NewBiologix SA launched its next-generation sequencing (NGS) and optical mapping platform. This advanced suite of integrated technologies is designed to provide comprehensive genomic analysis services, specifically tailored to meet the needs of the biopharmaceutical industry. Thus, advancements in NGS platforms are playing a pivotal role in driving the growth of the NGS market by enabling more comprehensive, accurate, and efficient genomic analysis for the biopharmaceutical industry.
Limitations associated with NGS technology are expected to hinder the next-generation sequencing (NGS) market
The idea of using NGS in ordinary clinical practice is difficult since these technologies can successfully identify clinically significant mutations, but they frequently fail to do so when larger sections of the genome are analyzed. The determination of the appropriate quality parameters, for example, could significantly aid in resolving these issues.
NGS technology will undoubtedly need measures for data management, process standardization and interpretation when it is introduced as a therapeutic tool. For the analysis of the enormous amount of data that these systems will produce, more emphasis should be placed on the work of biostatisticians and bioinformaticians.
Global Next Generation Sequencing (NGS) Market Segment Analysis
The global next-generation sequencing (NGS) market is segmented based on product type, application, technology, end user, and region.
Application:
The drug discovery segment is expected to hold 38.7% of the global next-generation sequencing (NGS) market
The drug discovery segment is increasingly driving the growth of the next-generation sequencing (NGS) market, as evidenced by strategic initiatives from leading companies. For instance, in December 2024, Alithea Genomics SA launched its MERCURIUS Full-Length DRUG-seq library preparation technology, uniquely integrating large-scale sample multiplexing, an extraction-free workflow, and full transcript coverage. Designed to streamline high-throughput RNA sequencing, this technology enables up to 384 full-length RNA-seq library preparations in a single tube, making it particularly valuable for accelerating transcriptomic profiling in drug screening and target validation.
Similarly, in September 2024, Takara Bio Europe introduced the Shasta Single-Cell System at the 2024 Human Cell Atlas General Meeting, a high-throughput NGS platform designed to advance drug discovery by enabling novel biomarker identification in oncology research. This innovative system integrates robust chemistries with intuitive bioinformatics tools, allowing researchers to analyze genomic and transcriptomic data from significantly larger numbers of cells, thereby enhancing the efficiency and scalability of early-stage drug and biomarker discovery efforts. These developments are expected to increase the demand which are used in drug discovery, which further increases the segment’s proportion in the overall market growth, making it a dominant segment.
Global Next Generation Sequencing (NGS) Market Geographical Analysis
North America is expected to hold 39.4% of the global next-generation sequencing (NGS) market
The growing demand for next-generation sequencing (NGS) in healthcare research is creating significant opportunities for manufacturers to expand operations across North America. With a large concentration of producers and suppliers, combined with rapid economic growth, the region has seen increased industrial output, which in turn is driving the uptake of NGS technologies. For instance, in October 2024, Illumina recently launched the MiSeq i100 Series, a new line of compact, user-friendly sequencing systems designed to make next-generation sequencing more accessible. The MiSeq i100 and i100 Plus offer rapid turnaround, affordable operation, and room-temperature reagent storage, helping labs start sequencing immediately
Furthermore, collaborative research initiatives between healthcare organizations and industry players, along with continuous innovation in product development aimed at enhancing diagnostic and treatment capabilities, are fueling further demand. Thus, North America continues to strengthen its dominant position in the global NGS market.
Asia-Pacific is expected to hold 27.2% of the global next-generation sequencing (NGS) market
The Asia-Pacific region is expected to be the fastest-growing market in the next-generation sequencing (NGS) sector due to a combination of rising healthcare investments, large and genetically diverse populations, and strong government initiatives. The region’s vast population provides a rich resource for genetic research, driving demand for personalized medicine, diagnostics, and targeted therapies.
Global Next Generation Sequencing (NGS) Market Competitive Landscape
The top companies in the next-generation sequencing (NGS) market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Qiagen, Eurofins Scientific, Revvity (PerkinElmer Inc.), Takara Bio Inc., Illumina Inc., Alithea Genomics SA, and NewBiologix SA, among others.
The global next-generation sequencing (NGS) market report delivers a detailed analysis with 57 key tables, more than 46 visually impactful figures, and 168 pages of expert insights, providing a complete view of the market landscape.
The global next-generation sequencing (NGS) market size reached US$ 13.42 Billion in 2024 and is expected to reach US$ 35.92 Billion by 2033, growing at a CAGR of 11.6% during the forecast period 2025-2033.
Sequencing on NGS includes several significant processes. For instance, DNA next-generation sequencing (NGS) calls for library preparation, bioinformatics analysis, DNA fragmentation, enormous parallel sequencing, and variant/mutation identification and interpretation. Furthermore, rising consumer demand for NGS due to the rising availability of products and technologies, an increase in the number of authorized service providers in the market, and an increase in drug discovery research are driving up the next-generation sequencing (NGS) market size.
The market is experiencing a growing demand for products from North American areas due to the rising advancements in this field. Significant competitors like Thermo Fisher Scientific Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., and others are actively operating in the market.
Global Next Generation Sequencing (NGS) Market Dynamics: Drivers & Restraints
The advancements in NGS platforms are expected to drive the market
The increase in demand for next-generation sequencing (NGS) for various applications, novel technology launches, recent developments in therapeutics, surging research, and novel product launches are likely to fuel the global next-generation sequencing (NGS) market size expansion throughout the forecast period.
For instance, in February 2025, Roche launched its proprietary Sequencing by Expansion (SBX) technology, a breakthrough in next-generation sequencing that delivers ultra-fast, high-throughput, and scalable genomic analysis. This innovation enhances the ability to decode complex diseases like cancer and neurodegenerative disorders by providing deeper insights into gene functions and interactions.
Nucleic acid sequencing has benefited from technological advancements in terms of technical proficiency. For instance, in April 2024, NewBiologix SA launched its next-generation sequencing (NGS) and optical mapping platform. This advanced suite of integrated technologies is designed to provide comprehensive genomic analysis services, specifically tailored to meet the needs of the biopharmaceutical industry. Thus, advancements in NGS platforms are playing a pivotal role in driving the growth of the NGS market by enabling more comprehensive, accurate, and efficient genomic analysis for the biopharmaceutical industry.
Limitations associated with NGS technology are expected to hinder the next-generation sequencing (NGS) market
The idea of using NGS in ordinary clinical practice is difficult since these technologies can successfully identify clinically significant mutations, but they frequently fail to do so when larger sections of the genome are analyzed. The determination of the appropriate quality parameters, for example, could significantly aid in resolving these issues.
NGS technology will undoubtedly need measures for data management, process standardization and interpretation when it is introduced as a therapeutic tool. For the analysis of the enormous amount of data that these systems will produce, more emphasis should be placed on the work of biostatisticians and bioinformaticians.
Global Next Generation Sequencing (NGS) Market Segment Analysis
The global next-generation sequencing (NGS) market is segmented based on product type, application, technology, end user, and region.
Application:
The drug discovery segment is expected to hold 38.7% of the global next-generation sequencing (NGS) market
The drug discovery segment is increasingly driving the growth of the next-generation sequencing (NGS) market, as evidenced by strategic initiatives from leading companies. For instance, in December 2024, Alithea Genomics SA launched its MERCURIUS Full-Length DRUG-seq library preparation technology, uniquely integrating large-scale sample multiplexing, an extraction-free workflow, and full transcript coverage. Designed to streamline high-throughput RNA sequencing, this technology enables up to 384 full-length RNA-seq library preparations in a single tube, making it particularly valuable for accelerating transcriptomic profiling in drug screening and target validation.
Similarly, in September 2024, Takara Bio Europe introduced the Shasta Single-Cell System at the 2024 Human Cell Atlas General Meeting, a high-throughput NGS platform designed to advance drug discovery by enabling novel biomarker identification in oncology research. This innovative system integrates robust chemistries with intuitive bioinformatics tools, allowing researchers to analyze genomic and transcriptomic data from significantly larger numbers of cells, thereby enhancing the efficiency and scalability of early-stage drug and biomarker discovery efforts. These developments are expected to increase the demand which are used in drug discovery, which further increases the segment’s proportion in the overall market growth, making it a dominant segment.
Global Next Generation Sequencing (NGS) Market Geographical Analysis
North America is expected to hold 39.4% of the global next-generation sequencing (NGS) market
The growing demand for next-generation sequencing (NGS) in healthcare research is creating significant opportunities for manufacturers to expand operations across North America. With a large concentration of producers and suppliers, combined with rapid economic growth, the region has seen increased industrial output, which in turn is driving the uptake of NGS technologies. For instance, in October 2024, Illumina recently launched the MiSeq i100 Series, a new line of compact, user-friendly sequencing systems designed to make next-generation sequencing more accessible. The MiSeq i100 and i100 Plus offer rapid turnaround, affordable operation, and room-temperature reagent storage, helping labs start sequencing immediately
Furthermore, collaborative research initiatives between healthcare organizations and industry players, along with continuous innovation in product development aimed at enhancing diagnostic and treatment capabilities, are fueling further demand. Thus, North America continues to strengthen its dominant position in the global NGS market.
Asia-Pacific is expected to hold 27.2% of the global next-generation sequencing (NGS) market
The Asia-Pacific region is expected to be the fastest-growing market in the next-generation sequencing (NGS) sector due to a combination of rising healthcare investments, large and genetically diverse populations, and strong government initiatives. The region’s vast population provides a rich resource for genetic research, driving demand for personalized medicine, diagnostics, and targeted therapies.
Global Next Generation Sequencing (NGS) Market Competitive Landscape
The top companies in the next-generation sequencing (NGS) market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Qiagen, Eurofins Scientific, Revvity (PerkinElmer Inc.), Takara Bio Inc., Illumina Inc., Alithea Genomics SA, and NewBiologix SA, among others.
The global next-generation sequencing (NGS) market report delivers a detailed analysis with 57 key tables, more than 46 visually impactful figures, and 168 pages of expert insights, providing a complete view of the market landscape.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Application
2.5. Snippet by Technology
2.6. Snippet by End User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Advancements in NGS Platforms
3.1.1.2. Drug Discovery Applications Demanding NGS Technology
3.1.2. Restraints
3.1.2.1. Limitations Associated with NGS Technology
3.1.2.2. Lack of Expertise
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Rising Research and Development
3.1.3.2. XX
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. Latin America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. NEXT GENERATION SEQUENCING (NGS) MARKET PRODUCT TYPE OUTLOOK
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Reagents and Consumables*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Instruments
5.4. Others
6. NEXT GENERATION SEQUENCING (NGS) MARKET APPLICATION OUTLOOK
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
6.1.2. Market Attractiveness Index, By Application
6.2. Agriculture and Animal Research*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Drug Discovery
6.4. Diagnostics
6.5. Genetic Screening
6.6. Others
7. NEXT GENERATION SEQUENCING (NGS) MARKET TECHNOLOGY OUTLOOK
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Whole Genome Sequencing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chip Sequencing
7.4. De Novo Sequencing
7.5. RNA Sequencing
7.6. Methyl Sequencing
7.7. Others
8. NEXT GENERATION SEQUENCING (NGS) MARKET END USER OUTLOOK
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals and Diagnostic Centers*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Biotechnology and Pharmaceutical Companies
8.4. Academic & Research Institutes
8.5. Others
9. NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. UK
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. China
9.4.7.2. India
9.4.7.3. Japan
9.4.7.4. South Korea
9.4.7.5. Rest of Asia-Pacific
9.5. South America
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. Brazil
9.5.7.2. Argentina
9.5.7.3. Rest of South America
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Thermo Fisher Scientific Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.2.3. Historic and Forecasted Product Sales
11.1.2.4. Product Sales Volume
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.5. SWOT Analysis
11.2. Agilent Technologies, Inc.
11.3. Bio-Rad Laboratories, Inc.
11.4. Qiagen
11.5. Eurofins Scientific
11.6. Revvity (PerkinElmer Inc.)
11.7. Takara Bio Inc.
11.8. Illumina Inc.
11.9. Alithea Genomics SA
11.10. NewBiologix SA
LIST NOT EXHAUSTIVE
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Application
2.5. Snippet by Technology
2.6. Snippet by End User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Advancements in NGS Platforms
3.1.1.2. Drug Discovery Applications Demanding NGS Technology
3.1.2. Restraints
3.1.2.1. Limitations Associated with NGS Technology
3.1.2.2. Lack of Expertise
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Rising Research and Development
3.1.3.2. XX
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. Latin America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. NEXT GENERATION SEQUENCING (NGS) MARKET PRODUCT TYPE OUTLOOK
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Reagents and Consumables*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Instruments
5.4. Others
6. NEXT GENERATION SEQUENCING (NGS) MARKET APPLICATION OUTLOOK
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
6.1.2. Market Attractiveness Index, By Application
6.2. Agriculture and Animal Research*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Drug Discovery
6.4. Diagnostics
6.5. Genetic Screening
6.6. Others
7. NEXT GENERATION SEQUENCING (NGS) MARKET TECHNOLOGY OUTLOOK
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Whole Genome Sequencing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chip Sequencing
7.4. De Novo Sequencing
7.5. RNA Sequencing
7.6. Methyl Sequencing
7.7. Others
8. NEXT GENERATION SEQUENCING (NGS) MARKET END USER OUTLOOK
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals and Diagnostic Centers*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Biotechnology and Pharmaceutical Companies
8.4. Academic & Research Institutes
8.5. Others
9. NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. UK
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. China
9.4.7.2. India
9.4.7.3. Japan
9.4.7.4. South Korea
9.4.7.5. Rest of Asia-Pacific
9.5. South America
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. Brazil
9.5.7.2. Argentina
9.5.7.3. Rest of South America
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Thermo Fisher Scientific Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.2.3. Historic and Forecasted Product Sales
11.1.2.4. Product Sales Volume
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.5. SWOT Analysis
11.2. Agilent Technologies, Inc.
11.3. Bio-Rad Laboratories, Inc.
11.4. Qiagen
11.5. Eurofins Scientific
11.6. Revvity (PerkinElmer Inc.)
11.7. Takara Bio Inc.
11.8. Illumina Inc.
11.9. Alithea Genomics SA
11.10. NewBiologix SA
LIST NOT EXHAUSTIVE
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
LIST OF TABLES
Table 1 Global Next Generation Sequencing (NGS) Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Next Generation Sequencing (NGS) Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Next Generation Sequencing (NGS) Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Next Generation Sequencing (NGS) Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Next Generation Sequencing (NGS) Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Next Generation Sequencing (NGS) Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 8 Global Next Generation Sequencing (NGS) Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 10 Global Next Generation Sequencing (NGS) Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 12 Global Next Generation Sequencing (NGS) Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 14 Global Next Generation Sequencing (NGS) Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Next Generation Sequencing (NGS) Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 17 North America Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 18 North America Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 19 North America Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 20 North America Next Generation Sequencing (NGS) Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 South America Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 South America Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 23 South America Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 24 South America Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 25 South America Next Generation Sequencing (NGS) Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Europe Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 27 Europe Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 28 Europe Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 29 Europe Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 30 Europe Next Generation Sequencing (NGS) Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 Asia-Pacific Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 32 Asia-Pacific Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 33 Asia-Pacific Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 34 Asia-Pacific Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 35 Asia-Pacific Next Generation Sequencing (NGS) Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Next Generation Sequencing (NGS) Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Thermo Fisher Scientific Inc.: Overview
Table 42 Thermo Fisher Scientific Inc.: Product Portfolio
Table 43 Thermo Fisher Scientific Inc.: Key Developments
Table 44 Agilent Technologies, Inc.: Overview
Table 45 Agilent Technologies, Inc.: Product Portfolio
Table 46 Agilent Technologies, Inc.: Key Developments
Table 47 Bio-Rad Laboratories, Inc.: Overview
Table 48 Bio-Rad Laboratories, Inc.: Product Portfolio
Table 49 Bio-Rad Laboratories, Inc.: Key Developments
Table 50 Qiagen: Overview
Table 51 Qiagen: Product Portfolio
Table 52 Qiagen: Key Developments
Table 53 Eurofins Scientific: Overview
Table 54 Eurofins Scientific: Product Portfolio
Table 55 Eurofins Scientific: Key Developments
Table 56 Revvity (PerkinElmer Inc.): Overview
Table 57 Revvity (PerkinElmer Inc.): Product Portfolio
Table 58 Revvity (PerkinElmer Inc.): Key Developments
Table 59 Takara Bio Inc.: Overview
Table 60 Takara Bio Inc.: Product Portfolio
Table 61 Takara Bio Inc.: Key Developments
Table 62 Illumina Inc.: Overview
Table 63 Illumina Inc.: Product Portfolio
Table 64 Illumina Inc.: Key Developments
Table 65 Alithea Genomics SA: Overview
Table 66 Alithea Genomics SA: Product Portfolio
Table 67 Alithea Genomics SA: Key Developments
Table 68 NewBiologix SA: Overview
Table 69 NewBiologix SA: Product Portfolio
Table 70 NewBiologix SA: Key Developments
Table 1 Global Next Generation Sequencing (NGS) Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Next Generation Sequencing (NGS) Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Next Generation Sequencing (NGS) Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Next Generation Sequencing (NGS) Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Next Generation Sequencing (NGS) Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Next Generation Sequencing (NGS) Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 8 Global Next Generation Sequencing (NGS) Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 10 Global Next Generation Sequencing (NGS) Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 12 Global Next Generation Sequencing (NGS) Market Value, By End User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 14 Global Next Generation Sequencing (NGS) Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Next Generation Sequencing (NGS) Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 17 North America Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 18 North America Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 19 North America Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 20 North America Next Generation Sequencing (NGS) Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 South America Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 South America Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 23 South America Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 24 South America Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 25 South America Next Generation Sequencing (NGS) Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Europe Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 27 Europe Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 28 Europe Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 29 Europe Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 30 Europe Next Generation Sequencing (NGS) Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 Asia-Pacific Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 32 Asia-Pacific Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 33 Asia-Pacific Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 34 Asia-Pacific Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 35 Asia-Pacific Next Generation Sequencing (NGS) Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Next Generation Sequencing (NGS) Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Next Generation Sequencing (NGS) Market Value, By Application, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Next Generation Sequencing (NGS) Market Value, By Technology, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Next Generation Sequencing (NGS) Market Value, By End User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Next Generation Sequencing (NGS) Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Thermo Fisher Scientific Inc.: Overview
Table 42 Thermo Fisher Scientific Inc.: Product Portfolio
Table 43 Thermo Fisher Scientific Inc.: Key Developments
Table 44 Agilent Technologies, Inc.: Overview
Table 45 Agilent Technologies, Inc.: Product Portfolio
Table 46 Agilent Technologies, Inc.: Key Developments
Table 47 Bio-Rad Laboratories, Inc.: Overview
Table 48 Bio-Rad Laboratories, Inc.: Product Portfolio
Table 49 Bio-Rad Laboratories, Inc.: Key Developments
Table 50 Qiagen: Overview
Table 51 Qiagen: Product Portfolio
Table 52 Qiagen: Key Developments
Table 53 Eurofins Scientific: Overview
Table 54 Eurofins Scientific: Product Portfolio
Table 55 Eurofins Scientific: Key Developments
Table 56 Revvity (PerkinElmer Inc.): Overview
Table 57 Revvity (PerkinElmer Inc.): Product Portfolio
Table 58 Revvity (PerkinElmer Inc.): Key Developments
Table 59 Takara Bio Inc.: Overview
Table 60 Takara Bio Inc.: Product Portfolio
Table 61 Takara Bio Inc.: Key Developments
Table 62 Illumina Inc.: Overview
Table 63 Illumina Inc.: Product Portfolio
Table 64 Illumina Inc.: Key Developments
Table 65 Alithea Genomics SA: Overview
Table 66 Alithea Genomics SA: Product Portfolio
Table 67 Alithea Genomics SA: Key Developments
Table 68 NewBiologix SA: Overview
Table 69 NewBiologix SA: Product Portfolio
Table 70 NewBiologix SA: Key Developments
LIST OF FIGURES
Figure 1 Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 4 Global Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 5 Global Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 6 Global Next Generation Sequencing (NGS) Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Next Generation Sequencing (NGS) Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 8 Reagents and Consumables Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 9 Instruments Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 10 Others Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 11 Global Next Generation Sequencing (NGS) Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 12 Agriculture and Animal Research Application in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 13 Drug Discovery Application in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 14 Diagnostics Application in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 15 Genetic Screening Application in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 16 Others Application in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 17 Global Next Generation Sequencing (NGS) Market Y-o-Y Growth, By Technology, 2023-2033 (%)
Figure 18 Whole Genome Sequencing Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 19 Chip Sequencing Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 20 De Novo Sequencing Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 21 RNA Sequencing Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 22 Methyl Sequencing Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 23 Others Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 24 Global Next Generation Sequencing (NGS) Market Y-o-Y Growth, By End User, 2023-2033 (%)
Figure 25 Hospitals and Diagnostic Centers End User in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 26 Biotechnology and Pharmaceutical Companies End User in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 27 Academic & Research Institutes End User in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 28 Others End User in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 29 Global Next Generation Sequencing (NGS) Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 30 North America Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 31 North America Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 32 North America Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 33 North America Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 34 North America Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 35 North America Next Generation Sequencing (NGS) Market Share, By Country, 2024 & 2033 (%)
Figure 36 South America Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 37 South America Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 38 South America Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 39 South America Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 40 South America Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 41 South America Next Generation Sequencing (NGS) Market Share, By Country, 2024 & 2033 (%)
Figure 42 Europe Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 43 Europe Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 44 Europe Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 45 Europe Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 46 Europe Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 47 Europe Next Generation Sequencing (NGS) Market Share, By Country, 2024 & 2033 (%)
Figure 48 Asia-Pacific Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 49 Asia-Pacific Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 50 Asia-Pacific Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 51 Asia-Pacific Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 52 Asia-Pacific Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 53 Asia-Pacific Next Generation Sequencing (NGS) Market Share, By Country, 2024 & 2033 (%)
Figure 54 Middle East and Africa Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 55 Middle East and Africa Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 56 Middle East and Africa Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 57 Middle East and Africa Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 58 Middle East and Africa Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 59 Thermo Fisher Scientific Inc.: Financials
Figure 60 Agilent Technologies, Inc.: Financials
Figure 61 Bio-Rad Laboratories, Inc.: Financials
Figure 62 Qiagen: Financials
Figure 63 Eurofins Scientific: Financials
Figure 64 Revvity (PerkinElmer Inc.): Financials
Figure 65 Takara Bio Inc.: Financials
Figure 66 Illumina Inc.: Financials
Figure 67 Alithea Genomics SA: Financials
Figure 68 NewBiologix SA: Financials
Figure 1 Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 4 Global Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 5 Global Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 6 Global Next Generation Sequencing (NGS) Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Next Generation Sequencing (NGS) Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 8 Reagents and Consumables Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 9 Instruments Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 10 Others Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 11 Global Next Generation Sequencing (NGS) Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 12 Agriculture and Animal Research Application in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 13 Drug Discovery Application in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 14 Diagnostics Application in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 15 Genetic Screening Application in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 16 Others Application in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 17 Global Next Generation Sequencing (NGS) Market Y-o-Y Growth, By Technology, 2023-2033 (%)
Figure 18 Whole Genome Sequencing Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 19 Chip Sequencing Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 20 De Novo Sequencing Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 21 RNA Sequencing Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 22 Methyl Sequencing Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 23 Others Technology in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 24 Global Next Generation Sequencing (NGS) Market Y-o-Y Growth, By End User, 2023-2033 (%)
Figure 25 Hospitals and Diagnostic Centers End User in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 26 Biotechnology and Pharmaceutical Companies End User in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 27 Academic & Research Institutes End User in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 28 Others End User in Global Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 29 Global Next Generation Sequencing (NGS) Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 30 North America Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 31 North America Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 32 North America Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 33 North America Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 34 North America Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 35 North America Next Generation Sequencing (NGS) Market Share, By Country, 2024 & 2033 (%)
Figure 36 South America Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 37 South America Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 38 South America Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 39 South America Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 40 South America Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 41 South America Next Generation Sequencing (NGS) Market Share, By Country, 2024 & 2033 (%)
Figure 42 Europe Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 43 Europe Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 44 Europe Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 45 Europe Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 46 Europe Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 47 Europe Next Generation Sequencing (NGS) Market Share, By Country, 2024 & 2033 (%)
Figure 48 Asia-Pacific Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 49 Asia-Pacific Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 50 Asia-Pacific Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 51 Asia-Pacific Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 52 Asia-Pacific Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 53 Asia-Pacific Next Generation Sequencing (NGS) Market Share, By Country, 2024 & 2033 (%)
Figure 54 Middle East and Africa Next Generation Sequencing (NGS) Market Value, 2022-2033 (US$ Billion)
Figure 55 Middle East and Africa Next Generation Sequencing (NGS) Market Share, By Product Type, 2024 & 2033 (%)
Figure 56 Middle East and Africa Next Generation Sequencing (NGS) Market Share, By Application, 2024 & 2033 (%)
Figure 57 Middle East and Africa Next Generation Sequencing (NGS) Market Share, By Technology, 2024 & 2033 (%)
Figure 58 Middle East and Africa Next Generation Sequencing (NGS) Market Share, By End User, 2024 & 2033 (%)
Figure 59 Thermo Fisher Scientific Inc.: Financials
Figure 60 Agilent Technologies, Inc.: Financials
Figure 61 Bio-Rad Laboratories, Inc.: Financials
Figure 62 Qiagen: Financials
Figure 63 Eurofins Scientific: Financials
Figure 64 Revvity (PerkinElmer Inc.): Financials
Figure 65 Takara Bio Inc.: Financials
Figure 66 Illumina Inc.: Financials
Figure 67 Alithea Genomics SA: Financials
Figure 68 NewBiologix SA: Financials
